Cannabis
Nimbus and Viva Care Medical Group Health form strategic partnership to offer medical cannabis access via telehealth to patients
Nimbus, an information technology healthcare provider in the medical cannabis industry, and Viva Care Medical Group, a chain of clinics in BC, today announced a strategic partnership to integrate Nimbus’ telehealth offerings within Viva Care clinics and their online presence. This strategic partnership promises to improve access to medical cannabis education and authorizations to patients.
Nimbus will be bringing its secure and state of the art telehealth and education platform to Viva Care patients who are interested in accessing medical cannabis.
“Many family physicians are not yet comfortable with authorizing medical cannabis prescriptions for their patients,” states Nimbus CEO, David Pham. “As we work to help educate physicians, we will concurrently offer telehealth prescribing so that patients can access the cannabis medical treatment that they require.” A survey of physicians in June 2018 by MD Analytics found that only 32% of physicians approved of cannabis legalization.
“Securing this exclusive agreement with Viva Care, a leading health clinic with over 10 locations in British Columbia, will allow for Nimbus to supply an industry leading telehealth solution that meets the growing demand for medicinal cannabis as an alternative and effective treatment offered to patients”, said David Pham, CEO of Nimbus.” Viva Care is also a telehealth care system that relieves patients of the need to travel around to find a suitable physician in obtaining prompt and quality continuous care. We are very excited about our new partnership with Viva Care and look forward to forging many more alliances as we roll out our strategic plan.”
SOURCE GET NIMBUS INC
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
Cannabis7 days ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan3 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf4 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis3 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care